This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Donohoe, S Articles by Machin, S Search for Related Content PubMed PubMed Citation Articles by Donohoe, S Articles by Machin, S Social Bookmarking                         What's this?

Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal andheparin-treated antiphospholipid syndrome pregnancies

Haemostasis Research Unit, Department of Haematology, University College London Medical School, 98 Chenies Mews, London WC1E 6HX, UK

S Quenby

Department of Obstetrics, Liverpool Women's Hospital, Liverpool, UK

I Mackie

Department of Haematology, University College London Medical School, London,UK

G Panal

Department of Obstetrics, University College London Medical School, London, UK

R Farquharson

Department of Obstetrics, Liverpool Women's Hospital, Liverpool, UK

R Malia

Department of Haematology,Royal Hallamshire Hospital, Shefield, UK

J Kingdom

Department of Obstetrics, University College London Medical School, London, UK

S Machin

Department of Haematology, University College London Medical School, London, UK

Antiphospholipidantibodies (aPL) are associated with anincreased risk of thrombosis and recurrent miscarriage. Weassessed levels of coagulation activation markers and aPL during normal pregnancy and in women with the antiphospholipid syndrome (aPS). Fluctuations in aPL levels were observed in all patients with aPS. No particular pattern of antibody positivity, or fluctuation in aPL level,was associated with poor pregnancy outcome. A significant increase was observed in levels of factor XIIa(FXIIa; P 0.001), factor VIIa (FVIIa, P 0.001), thrombin antithrombin complexes (TAT; P 0.001), prothrombin fragment F1.2 (F1.2; P 0.001) and D-dimer (DD; P 0.05) during normalpregnancy. Factor VIIa, TAT, F1.2 and DD increased significantly before 20 weeks gestation, while a statistically significant increase in FXIIa levels was first detected between weeks 20 and 30 of gestation. In pregnant women with aPS, increases in FXIIa were similar to those in normal pregnancy, but increasedFVIIa levels were not observed until after 30 weeks gestation.Similar to normal pregnancy, increased levels of TATandF1.2 were detected in aPS pregnancies before 20 weeks gestation, but increased DD were not observed until afterweek 20. Surprisingly, women with aPS receiving low molecular weight heparin prophylaxis had significantly higher (P 0.02) levels of TAT (median 8.6; interquartile range (IQR) 6.5–20.8) between weeks 20 and 30 of gestation compared to the normal pregnant population (median 5.9; IQR 4.7–7.9), thus indicating increased thrombin generationin women with aPS in mid-pregnancy.

Key Words: coagulation activation markers • antiphospholipid antibody • pregnancy • heparin

Lupus, Vol. 11, No. 1, 11-20 (2002)
DOI: 10.1191/0961203302lu132oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. S. Nielsen and O. B. Christiansen Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant Hum. Reprod., June 1, 2005; 20(6): 1720 - 1728. [Abstract] [Full Text] [PDF]